Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16184
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPhillipou, Andrea-
dc.contributor.authorRossell, Susan L-
dc.contributor.authorWilding, Helen E-
dc.contributor.authorCastle, David J-
dc.date2016-08-05-
dc.date.accessioned2016-09-05T06:42:03Z-
dc.date.available2016-09-05T06:42:03Z-
dc.date.issued2016-11-
dc.identifier.citationPsychiatry research 2016; 245: 179-185en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16184-
dc.description.abstractTreatment for body dysmorphic disorder (BDD) often involves a combination of psychological and pharmacological interventions. However, only a small number of randomised controlled trials (RCTs) have been undertaken examining the efficacy of different therapeutic interventions. The aim of this study was to systematically review the RCTs involving psychological and pharmacological interventions for the treatment of BDD. The literature was searched to June 2015, and studies were included if they were written in English, empirical research papers published in peer-review journals, specifically assessed BDD patients, and involved a RCT assessing BDD symptoms pre- and post-intervention. Nine studies were identified: six involving psychological and three involving pharmacological interventions. Cognitive behaviour therapy, metacognitive therapy and selective serotonin reuptake inhibitors were identified as treatments with potential benefit. The small number of RCTs and the heterogeneity of findings emphasises the need for more high quality RCTs assessing both psychological and pharmacological interventions for BDD.en_US
dc.subjectCognitive therapyen_US
dc.subjectBody dysmorphic disordersen_US
dc.subjectBehaviour therapyen_US
dc.subjectSerotonin and noradrenaline reuptake inhibitorsen_US
dc.titleRandomised controlled trials of psychological & pharmacological treatments for body dysmorphic disorder: A systematic reviewen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitlePsychiatry Researchen_US
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Psychiatry, St Vincent's Hospital, Fitzroy, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Mental Health, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationBrain & Psychological Sciences Research Centre, Swinburne University of Technology, Hawthorn, Victoria, Australiaen_US
dc.identifier.affiliationMonash Alfred Psychiatry Research Centre, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationFaculty of Health Sciences, Australian Catholic University, Fitzroy, Victoria, Australiaen_US
dc.type.studyortrialReviews/Systematic Reviewsen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27544783en_US
dc.identifier.doi10.1016/j.psychres.2016.05.062en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherPhillipou, Andrea
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptMental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

26
checked on Jan 15, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.